Home / Share Price Target / Sunpharma
Sun Pharma Share Price Target 2024, 2025, 2026 to 2040 With Charts
Sun Pharmaceutical Industries Limited | |||
Symbol: SUNPHARMA | |||
Price: ₹1,801.05 | |||
Exchange: NSE | |||
Healthcare -> Drug Manufacturers—Specialty & Generic |
Show Table of Contents
Table of Contents
- 1: Sun Pharma Brief Company Overview
- 1.1: Sun Pharmaceutical Industries Limited: A Pharmaceutical Powerhouse
- 1.2: Sun Pharma Financial Performance
- 1.2.1: Is Sun Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Sun Pharma Share Price Target For 2024
- 2.1.1: Sun Pharma Share Price Target Table For 2024
- 2.1.2: Summary: Sun Pharma Share Price Prediction For 2024
- 2.2: Sun Pharma Share Price Target For 2025
- 2.2.1: Sun Pharma Share Price Target Table For 2025
- 2.2.2: Summary: Sun Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Sun Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2040
- 3.2: Sun Pharma Share Price Target Table From 2024, 2025, 2026 to 2040
- 4: Sun Pharma Past Performance
Sun Pharma Brief Company Overview
Sun Pharmaceutical Industries Limited: A Pharmaceutical Powerhouse
Sun Pharmaceutical Industries Limited is a renowned generic pharmaceutical company with a global reach. Established in 1983, the company has become a leading provider of branded and generic formulations, as well as active pharmaceutical ingredients (APIs).
Sun Pharma's product portfolio covers a wide spectrum of therapeutic areas, including cardiology, neuropsychiatry, oncology, gastroenterology, and many more. The company also offers speciality medications, anti retro viral medications, and over-the-counter products.
With a commitment to innovation and customer satisfaction, Sun Pharma has earned a strong reputation in the industry. Its diverse product range, global presence, and unwavering commitment to quality have made it a trusted partner for healthcare professionals and patients alike.
Sun Pharma Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 3,67,433.4 Crore | Market valuation of Sun Pharma's shares. |
Revenue (TTM) | 47,444.62 Crore | Total revenue generated by Sun Pharma over the past twelve months. |
Net Income (TTM) | +8,906.27 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 22.05% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | 18.77% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | +10.1% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) | +16.5% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio | 3.05 | Company's total debt divided by total shareholder equity. |
Total Debt | 1,928.23 Crore | Sum of Sun Pharma's current & long-term financial obligations. |
Total Cash | 14,833.24 Crore | Total amount of liquid funds available to Sun Pharma. |
Beta | 0.52 | Beta is less than 1 indicating that the Sun Pharma's price is less volatile than the market. |
Is Sun Pharma A Good Buy For Long Term?
Sun Pharma, a large-cap stock with consistent revenue growth (9.6% QoQ) and profitability (33.8% YoY earnings growth), appears to be a promising investment for the long term. Its healthy profit margin (19.74%) and strong financial position with ample cash reserves of 19,105.22 Crore indicate the company's financial strength. While it does have some debt (3,273.67 Crore), its strong cash position mitigates any concerns. Overall, the company's impressive financial performance, coupled with its strong fundamentals, make it a suitable choice for long-term investors seeking steady growth and potential returns.
To predict the Sun Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Sun Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Sun Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sun Pharma shares in 2024, see the table below.
Sun Pharma Share Price Target Table For 2024
Sun Pharma's Levels | Value | Reason/Importance |
---|---|---|
2024 Target 3 | 1816.8 (+0.87%) | Price Action: 13 Dec 2024 High |
2024 Target 2 | 1814.9 (+0.76%) | Price Action: 08 Nov 2024 High |
2024 Target 1 | 1812.14 (+0.61%) | Technical Indicator: MA100 |
Current Price | 1801.05 | Sun Pharma's 1 share price as of Wed 18 Dec 2024 |
Stop Loss 1 | 1875.66 (+4.14%) | Fibonacci Retracement Level 23.599999999999998% |
Stop Loss 2 | 1846.56 (+2.52%) | Fibonacci Retracement Level 38.2% |
Stop Loss 3 | 1823.05 (+1.22%) | Fibonacci Retracement Level 50.0% |
Summary: Sun Pharma Share Price Prediction For 2024
In summary, Sun Pharma has surged by ₹541.60, achieving a notable +43.00% increase from 1st January 2024 to 18 Dec 2024. Our analysis of Sun Pharma for 2024 predicts an additional rise of 0.61% to 0.87% by the end of 2024 with three potential targets T1: 1812.14, T2: 1814.9, T3: 1816.8. Stop Loss at SL1: 1875.66, SL2: 1846.56, SL3: 1823.05.
Sun Pharma has a 52-week high of ₹1960.35, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1208.55, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Sun Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sun Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Sun Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sun Pharma shares in 2025, see the table below.
Sun Pharma Share Price Target Table For 2025
Sun Pharma's Levels | Value | Reason/Importance |
---|---|---|
2025 Target 3 | 2363.86 (+31.24%) | Price Action: Chart |
2025 Target 2 | 2319.78 (+28.8%) | Fibonacci Extension Level 150% |
2025 Target 1 | 2267.6 (+25.9%) | Fibonacci Extension Level 64.9% |
Current Price | 1801.05 | Sun Pharma's 1 share price as of Wed 18 Dec 2024 |
Stop Loss 1 | 1685.73 (-6.41%) | Fibonacci Retracement Level 38.2% |
Stop Loss 2 | 1668.87 (-7.34%) | Price Action: Chart |
Stop Loss 3 | 1633.66 (-9.3%) | Price Action: Apr 2024 High |
Summary: Sun Pharma Share Price Prediction For 2025
In summary, Sun Pharma has surged by ₹541.60, achieving a notable +43.00% increase from 1st January 2024 to 18 Dec 2024. Our analysis of Sun Pharma for 2025 predicts an additional rise of 25.9% to 31.24% by the end of 2025 with three potential targets T1: 2267.6, T2: 2319.78, T3: 2363.86. Stop Loss at SL1: 1685.73, SL2: 1668.87, SL3: 1633.66.
Sun Pharma has a All-Time high of ₹1959.30, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1208.55, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Sun Pharma, we have created a specific page for that check here: Sun Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Sun Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2040
This chart presents a detailed projection of Sun Pharma share price predictions from 2024, 2025, 2026 to 2040. This share price Prediction represents a CAGR of 10.81% over the next 15 years.
For complete year by year Sun Pharma long term share price target from 2024, 2025 to 2040 check the below table.
Sun Pharma Share Price Target Table From 2024, 2025, 2026 to 2040
Year | Sun Pharma Target | YoY Change % |
---|---|---|
2024 | ₹1,801.05 | [Current Price] |
2024 | ₹2,001.33 | 11.12% |
2025 | ₹2,429.98 | 21.41% |
2026 | ₹2,644.37 | 8.82% |
2027 | ₹3,078.64 | 16.42% |
2028 | ₹3,730.63 | 21.17% |
2029 | ₹4,151.75 | 11.28% |
2030 | ₹4,579.13 | 10.29% |
2031 | ₹4,631.6 | 1.14% |
2032 | ₹5,089.93 | 9.89% |
2033 | ₹5,886.23 | 15.64% |
2034 | ₹6,302.16 | 7.06% |
2035 | ₹6,728.28 | 6.76% |
2036 | ₹6,618.86 | -1.63% |
2037 | ₹7,101.24 | 7.28% |
2038 | ₹8,041.82 | 13.24% |
2039 | ₹8,425.73 | 4.77% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sun Pharma Past Performance
- In 1995, Sun Pharma opening price was ₹1.63
- As of Wed 18 Dec 2024 the price stands at ₹1,801.05.
- This represents a Compound Annual Growth Rate (CAGR) of 26.31%.
- In 29 years, an investment of 10,000 would have become ₹1.1 Crore.
As we wrap up, we hope you like our study on Sun Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Sun Pharma Share Price History
- Sun Pharma Price Target Tomorrow
- Sun Pharma Dividend History
- Sun Pharma Bonus History
- Sun Pharma Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.